Stephan D Kendall, MD in Salt Lake City, UT - Medicare Medical Oncology

Stephan D Kendall, MD is a medicare enrolled "Internal Medicine - Medical Oncology" physician in Salt Lake City, Utah. He went to Albany Medical College Of Union University and graduated in 1999 and has 25 years of diverse experience with area of expertise as Medical Oncology. He is a member of the group practice Utah Cancer Specialists Pc and his current practice location is 3838 S 700 E, Ste 100, Salt Lake City, Utah. You can reach out to his office (for appointments etc.) via phone at (801) 269-0231.

Stephan D Kendall is licensed to practice in Utah (license number 8654924-1205) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1033293196.

Contact Information

	Stephan D Kendall, MD
	3838 S 700 E, Ste 100, Salt Lake City, UT 84106-1466
	(801) 269-0231
	(801) 269-0304

Physician's Profile

Full Name	Stephan D Kendall
Gender	Male
Speciality	Medical Oncology
Experience	25 Years
Location	3838 S 700 E, Salt Lake City, Utah
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Stephan D Kendall attended and graduated from Albany Medical College Of Union University in 1999

NPI Data:

NPI Number: 1033293196
Provider Enumeration Date: 10/25/2006
Last Update Date: 10/10/2016

Medicare PECOS Information:

PECOS PAC ID: 3173567708
Enrollment ID: I20130729000448

Medical Identifiers

Medical identifiers for Stephan D Kendall such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1033293196	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207RH0003X	Internal Medicine - Hematology & Oncology	2002-01109 (North Carolina)	Secondary
207RH0003X	Internal Medicine - Hematology & Oncology	8654924-1205 (Utah)	Secondary
207RX0202X	Internal Medicine - Medical Oncology	8654924-1205 (Utah)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Intermountain Medical Center	Murray, UT	Hospital
St Mark's Hospital	Salt lake city, UT	Hospital
Alta View Hospital	Sandy, UT	Hospital
Lone Peak Hospital	Draper, UT	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Utah Cancer Specialists Pc	1355254749	39

News Archive

Medx Health Corp announces losses for the quarter ended June 30, 2009

MedX Health Corp., (TSXV.MDX) a global leader in drug free, non-invasive low level laser and light therapy for tissue repair and pain relief, today announced its results for the quarter ended June 30, 2009.

Model unravels rules that govern how genes are switched on and off

For years, scientists have struggled to decipher the genetic instruction book that details where and when the 20,000 genes in a human cell will be turned on or off.

Edimer doses first XLHED-affected neonate in Phase 2 trial of EDI200

Edimer Pharmaceuticals, a biotechnology company focused on developing an innovative therapy for the rare genetic disorder X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), today announced the enrollment and completed dosing of the first XLHED-affected neonate in a Phase 2 trial of EDI200, the company's novel, proprietary, recombinant protein.

Experimental Therapeutics, Debiopharm join to develop oral small molecules targeting new class of epigenetic modulators

The Agency for Science, Technology and Research (A*STAR)'s Experimental Therapeutics Centre (ETC), a center of excellence to advance and accelerate drug discovery in Singapore, and Debiopharm Group™ (Debiopharm), the Swiss-based global biopharmaceutical company that focuses on the development of prescription drugs that target unmet medical needs including oncology as well as companion diagnostics, today announced the signature of an exclusive research collaboration to develop oral small molecules targeting new class of epigenetic modulators.

Researchers identify cells responsible for maintenance and regeneration of liver

While the amazing regenerative power of the liver has been known since ancient times, the cells responsible for maintaining and replenishing the liver have remained a mystery.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Stephan D Kendall allows following entities to bill medicare on his behalf.

Entity Name	Utah Cancer Specialists Pc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1619925369 PECOS PAC ID: 1355254749 Enrollment ID: O20031111000618

News Archive

Medx Health Corp announces losses for the quarter ended June 30, 2009

Model unravels rules that govern how genes are switched on and off

For years, scientists have struggled to decipher the genetic instruction book that details where and when the 20,000 genes in a human cell will be turned on or off.

Edimer doses first XLHED-affected neonate in Phase 2 trial of EDI200

Experimental Therapeutics, Debiopharm join to develop oral small molecules targeting new class of epigenetic modulators

Researchers identify cells responsible for maintenance and regeneration of liver

While the amazing regenerative power of the liver has been known since ancient times, the cells responsible for maintaining and replenishing the liver have remained a mystery.

Entity Name	University Of Utah Adult Services
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1114321981 PECOS PAC ID: 0941525273 Enrollment ID: O20150209001683

Medx Health Corp announces losses for the quarter ended June 30, 2009

Model unravels rules that govern how genes are switched on and off

For years, scientists have struggled to decipher the genetic instruction book that details where and when the 20,000 genes in a human cell will be turned on or off.

Edimer doses first XLHED-affected neonate in Phase 2 trial of EDI200

Experimental Therapeutics, Debiopharm join to develop oral small molecules targeting new class of epigenetic modulators

Researchers identify cells responsible for maintenance and regeneration of liver

While the amazing regenerative power of the liver has been known since ancient times, the cells responsible for maintaining and replenishing the liver have remained a mystery.

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Stephan D Kendall is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Stephan D Kendall, MD 1121 E 3900 S, Ste C240, Salt Lake City, UT 84124-1214 Ph: (801) 262-9494	Stephan D Kendall, MD 3838 S 700 E, Ste 100, Salt Lake City, UT 84106-1466 Ph: (801) 269-0231

News Archive

Medx Health Corp announces losses for the quarter ended June 30, 2009

Model unravels rules that govern how genes are switched on and off

For years, scientists have struggled to decipher the genetic instruction book that details where and when the 20,000 genes in a human cell will be turned on or off.

Edimer doses first XLHED-affected neonate in Phase 2 trial of EDI200

Experimental Therapeutics, Debiopharm join to develop oral small molecules targeting new class of epigenetic modulators

Researchers identify cells responsible for maintenance and regeneration of liver

While the amazing regenerative power of the liver has been known since ancient times, the cells responsible for maintaining and replenishing the liver have remained a mystery.

Internal Medicine Doctors in Salt Lake City, UT

Dr. Mehmet Akkaya, M.D Internal Medicine Medicare: Medicare Enrolled Practice Location: University Of Utah Hospital Cardiology, 3o N,1900 E, Rm:4a100, Salt Lake City, UT 84132 Phone: 801-505-1689
Dr. Willard Dere, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 500 Foothill Blvd, Salt Lake City, UT 84148 Phone: 801-582-1565
Megan Meier, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 50 N Medical Dr, Salt Lake City, UT 84132 Phone: 801-581-2121
Joel Money, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 50 N Medical Dr, Salt Lake City, UT 84132 Phone: 801-581-2121
Mchale O. Anderson, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 30 N 1900 E Rm 4a100, Salt Lake City, UT 84132 Phone: 801-587-2451
Siddharth K. Iyengar, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 30 N 1900 E Rm 4c116, Salt Lake City, UT 84132 Phone: 801-581-7606
Taryn A. Young, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 5121 S Cottonwood St, Salt Lake City, UT 84107 Phone: 801-507-4384 Fax: 801-507-4398

Stephan D Kendall, MD - Medicare Medical Oncology in Salt Lake City, UT

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

Medx Health Corp announces losses for the quarter ended June 30, 2009

Model unravels rules that govern how genes are switched on and off

Edimer doses first XLHED-affected neonate in Phase 2 trial of EDI200

Experimental Therapeutics, Debiopharm join to develop oral small molecules targeting new class of epigenetic modulators

Researchers identify cells responsible for maintenance and regeneration of liver

Medicare Reassignments

Medx Health Corp announces losses for the quarter ended June 30, 2009

Model unravels rules that govern how genes are switched on and off

Edimer doses first XLHED-affected neonate in Phase 2 trial of EDI200

Experimental Therapeutics, Debiopharm join to develop oral small molecules targeting new class of epigenetic modulators

Researchers identify cells responsible for maintenance and regeneration of liver

Medx Health Corp announces losses for the quarter ended June 30, 2009

Model unravels rules that govern how genes are switched on and off

Edimer doses first XLHED-affected neonate in Phase 2 trial of EDI200

Experimental Therapeutics, Debiopharm join to develop oral small molecules targeting new class of epigenetic modulators

Researchers identify cells responsible for maintenance and regeneration of liver

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Medx Health Corp announces losses for the quarter ended June 30, 2009

Model unravels rules that govern how genes are switched on and off

Edimer doses first XLHED-affected neonate in Phase 2 trial of EDI200

Experimental Therapeutics, Debiopharm join to develop oral small molecules targeting new class of epigenetic modulators

Researchers identify cells responsible for maintenance and regeneration of liver

Internal Medicine Doctors in Salt Lake City, UT